These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32088858)

  • 21. Where are we with understanding of COVID-19?
    Akula SM; McCubrey JA
    Adv Biol Regul; 2020 Dec; 78():100738. PubMed ID: 32992235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Race to find COVID-19 treatments accelerates.
    Kupferschmidt K; Cohen J
    Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
    [No Abstract]   [Full Text] [Related]  

  • 23. A Novel Coronavirus (COVID-19) Outbreak: A Call for Action.
    Zhang Y; Xu J; Li H; Cao B
    Chest; 2020 Apr; 157(4):e99-e101. PubMed ID: 32087216
    [No Abstract]   [Full Text] [Related]  

  • 24. Coronavirus 2019-nCoV: A brief perspective from the front line.
    Han Q; Lin Q; Jin S; You L
    J Infect; 2020 Apr; 80(4):373-377. PubMed ID: 32109444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
    Ayaz S; Crea F
    Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
    [No Abstract]   [Full Text] [Related]  

  • 26. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
    [No Abstract]   [Full Text] [Related]  

  • 27. The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19.
    Panera N; Tozzi AE; Alisi A
    Drugs; 2020 Jul; 80(10):941-946. PubMed ID: 32451923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding of COVID-19 based on current evidence.
    Sun P; Lu X; Xu C; Sun W; Pan B
    J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
    Jogalekar MP; Veerabathini A; Gangadaran P
    Exp Biol Med (Maywood); 2020 Jun; 245(11):964-969. PubMed ID: 32306751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium for the 2019 novel coronavirus.
    Gómez-Bernal G
    Med Hypotheses; 2020 Sep; 142():109822. PubMed ID: 32408073
    [No Abstract]   [Full Text] [Related]  

  • 31. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
    Bifulco M; Gazzerro P
    Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathophysiology and treatment strategies for COVID-19.
    Kumar M; Al Khodor S
    J Transl Med; 2020 Sep; 18(1):353. PubMed ID: 32933536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the type of diabetes treatment relevant to outcome of COVID-19?
    Bloomgarden Z
    J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
    [No Abstract]   [Full Text] [Related]  

  • 35. Cryptic transmission of SARS-CoV-2 in Washington state.
    Bedford T; Greninger AL; Roychoudhury P; Starita LM; Famulare M; Huang ML; Nalla A; Pepper G; Reinhardt A; Xie H; Shrestha L; Nguyen TN; Adler A; Brandstetter E; Cho S; Giroux D; Han PD; Fay K; Frazar CD; Ilcisin M; Lacombe K; Lee J; Kiavand A; Richardson M; Sibley TR; Truong M; Wolf CR; Nickerson DA; Rieder MJ; Englund JA; ; Hadfield J; Hodcroft EB; Huddleston J; Moncla LH; Müller NF; Neher RA; Deng X; Gu W; Federman S; Chiu C; Duchin JS; Gautom R; Melly G; Hiatt B; Dykema P; Lindquist S; Queen K; Tao Y; Uehara A; Tong S; MacCannell D; Armstrong GL; Baird GS; Chu HY; Shendure J; Jerome KR
    Science; 2020 Oct; 370(6516):571-575. PubMed ID: 32913002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.
    Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B
    Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439
    [No Abstract]   [Full Text] [Related]  

  • 37. International Expansion of a Novel SARS-CoV-2 Mutant.
    Wang M; Li M; Ren R; Li L; Chen EQ; Li W; Ying B
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269121
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of lethal human coronaviruses.
    Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W
    Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.].
    Lvov DK; Alkhovsky SV; Kolobukhina LV; Burtseva EI
    Vopr Virusol; 2020; 65(1):6-15. PubMed ID: 32496715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.